Advanced Human Imaging Limited. SEC Filings

Welcome to our dedicated page for Advanced Human Imaging Limited. SEC filings (Ticker: AHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for Advanced Health Intelligence Ltd (AHI) provides access to the company’s U.S. regulatory disclosures, including reports related to its American Depositary Shares. These documents are an important source of information for investors researching the AHI stock, its listing history, and key corporate announcements.

Among the filings, a Form 25 submitted by Nasdaq Stock Market LLC in August 2025 formally notifies the removal of AHI’s American Depositary Shares from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. This filing identifies Advanced Health Intelligence Ltd as the issuer and The Nasdaq Stock Market LLC as the exchange, and confirms that the ADS class was struck from listing in accordance with applicable rules.

AHI also files Form 6‑K current reports as a foreign private issuer, which can include press releases and other information furnished to the SEC. For example, a Form 6‑K dated July 2025 references a press release titled “NASDAQ Update,” illustrating how the company uses this form to communicate listing-related developments and other material information to U.S. markets.

On this page, Stock Titan surfaces AHI’s SEC filings in one place and applies AI-powered summaries to help explain the contents of lengthy documents. Investors can quickly see which filings relate to listing status (such as Form 25), which are current reports (Form 6‑K), and how these disclosures fit into the broader history of Advanced Health Intelligence’s presence in U.S. public markets. For deeper analysis, users can open individual filings to review the full text as filed with the SEC.